mRNA |
Cerulenin |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.01 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.02 |
mRNA |
dinaciclib |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.02 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.02 |
mRNA |
alvocidib |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.02 |
mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.02 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.02 |
mRNA |
GSK690693 |
GDSC1000 |
pan-cancer |
AAC |
-0.074 |
0.02 |
mRNA |
17-AAG |
CCLE |
pan-cancer |
AAC |
0.11 |
0.02 |
mRNA |
BRD-A02303741 |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.02 |